pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 29·1 min read
save

David Chang to hand over the reins at Allogene; Ex-Esperion CEO gets started at Phlow

Longtime Allogene CEO David Chang will be stepping down at the end of June. Chang has served as the company’s CEO for the past eight years and will be succeeded by ...

May 29, 2026·read at Endpoints ↗

May 29, 2026 07:00 AM EDT Peer Review David Chang to hand over the reins at Al­lo­gene; Ex-Es­pe­ri­on CEO gets start­ed at Phlow Alex Hoffman Copy Chief and News Editor Lei Lei Wu News Reporter Kyle LaHucik Biotech Correspondent Long­time Al­lo­gene CEO David Chang will be step­ping down at the end of June. Chang has served as the com­pa­ny’s CEO … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
95 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 3h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 4h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 5h agoHealth tech investors are looking at bigger betsEndpoints
  • 7h agoSummit, Akeso say ivonescimab clears OS bar in Phase 3 lung cancer trialEndpoints